Phathom Pharmaceuticals, Inc. — Director's Dealing 2023

Jul 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2023-07-14

Reporting Person: Henderson Molly (CFO and CBO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-14	Common Stock	A	25000	$1.00	Acquired	95180	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1134.27	Indirect

Footnotes

F1: Represents restricted stock units ("RSUs") granted on July 14, 2023. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of July 14, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

F2: Includes 1,674 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2023.

F3: Includes 795.41 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.